Novartis AG 2020 SR
The report highlights Novartis's response to the COVID-19 pandemic, including the mobilization of R&D and a USD 40 million donation to impacted communities. Key achievements in 2020 include reaching 66 million patients through access activities and reducing greenhouse gas emissions by 19% compared to a 2016 baseline. The company launched a new Code of Ethics and issued its first sustainability-linked bond with social targets for patient reach in low- and middle-income countries. Novartis also set ambitious environmental goals, aiming for full carbon neutrality across its value chain by 2030.
Company: Novartis AG
Sector: Manufacturing
Country: Switzerland
Year: 2020
Type: SR
Pages: 94
Back to company
Novartis AG
ESG Report
The report highlights Novartis's response to the COVID-19 pandemic, including the mobilization of R&D and a USD 40 million donation to impacted communities. Key achievements in 2020 include reaching 66 million patients through access activities and reducing greenhouse gas emissions by 19% compared to a 2016 baseline. The company launched a new Code of Ethics and issued its first sustainability-linked bond with social targets for patient reach in low- and middle-income countries. Novartis also set ambitious environmental goals, aiming for full carbon neutrality across its value chain by 2030.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2020
Reporting Period
Jan 1, 2020 - Dec 31, 2020
Fiscal Year
2020
Published
Jan 25, 2021
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
Assurance Provider
Assurance Standard
Sustainable Development Goals
Other Standards
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Energy Consumption
Water Consumption
Women on Board
Women in Management
Net Zero Target
Employees